Clinical features

NAOQ19 n(%)

Placebo

n(%)

Intergroup p value between the 2 arms

D-1

D-5

D-10

D-1

D-5

D-10

D-1

D-5

D-10

Absence of Sore Throat

14 (56%)

23 (100%)

22 (100%)

12 (63.2%)

12 (63.2%)

16 (84.2%)

0.09

<0.001**

0.19

Absence of Anosmia (Normal Smell)

24 (48%)

16 (64%)

22 (100%)

9 (47.4%)

9 (47.4%)

10 (52.6%)

0.063

<0.001**

0

Absence of Hemoptysis

25(100%)

23(100%)

22(100%)

19(100%)

19(100%)

19(100%)

1.00

1.00

1.00

Absence of Shortness of breath

25(100%)

23(100%)

22(100%)

19(100%)

18(100%)

18(100%)

1.00

1.00

1.00

No Headache

6 (24%)

22 (100%)

21 (100%)

1 (5.3%)

4 (21.1%)

14 (73.7%)

0.084

<0.001**

0.037**

Absence of Joint Pain (No pain)

12 (48%)

16 (64%)

21 (100%)

5 (26.3%)

6 (31.6%)

6 (31.6%)

0.15

0.019**

<0.001**

Absent Runny nose

0 (0%)

18 (72%)

22 (100%)

1 (5.3%)

3 (15.8%)

13 (68.4%)

<0.001**

0.003**

0.013*

Absence of Sputum Formation

18 (72%)

23 (100%)

23 (100%)

13 (68.4%)

13 (68.4%)

15 (78.9%)

<0.001**

<0.001**

0.08

No Fatigue (can do normal work)

20(80%)

22(100%)

22(100%)

17(89.5%)

17(89.5%)

18(100%)

<0.001**

0.58

1

Fever (Afebrile)

16 (64%)

23 (100%)

23 (100%)

12 (63.2%)

18 (94.7%)

18 (100%)

<0.001**

0.45

1.00

Absence of Dry Cough

20(80%)

21(84%)

22(100%)

13(68.4%)

13(68.4%)

17(89.5%)

<0.001**

0.11

0.45

Absence of Aguesia (Normal

Taste)

11 (44%)

16 (64%)

22 (100%)

10 (52.6%)

10 (52.6%)

9 (47%)

0.011*

<0.001**

<0.001**